Key result
Body mass index showed no statistically significant correlation with mortality or survival (Pearson correlation -0.065, p=0.413) among chronic hemodialysis patients.
Why the study?
Data were lacking in the country on the correlation between obesity and comorbidities in dialysis patients, leaving unclear how BMI affects diabetic or cardiovascular disease patients on dialysis.
Cross-Sectional (n=160)
No
Effect estimate: Pearson Correlation -0.065
p-value: p=0.413
In a small cohort of hemodialysis patients, BMI was not significantly associated with survival differences related to cardiovascular disease or diabetes.
Cross-sectional links between BMI and comorbidities in dialysis patients remain unclear; leaves open need for longitudinal confirmation before clinical application.
INTRODUCTION: Nowadays, obesity is an enormous problem in the public health of undeveloped countries and developing countries. Being overweight, especially obesity in internal organs contributes to increased risk of metabolic and cardiovascular complications in patients with chronic kidney disease. There is no complete data available in our country on the correlation between obesity and comorbidity diseases among persons undergoing dialysis. So we do not know how BMI affects Diabetic or Cardio Vascular Disease (CVD) patients among dialysis patients. We, therefore, undertook this study to evaluate the association of obesity with mobility in hemodialysis patients at the Elbasan dialysis center. METHODOLOGY: This cross-sectional study was performed in 160 patients who have undergone the dialysis process at Elbasan Dialysis Center for three years (2016-2018). A standardized questionnaire was adopted to obtain data from all patients. The subjects were divided a priory into 4 categories based on the body mass index (BMI) (underweight <19, normal 19-25, pre-obese 25-30 and obese ≥30 kg/m2). Software SPSS version 20.0 is used to analyze and evaluate the data. Kaplan-Meier estimate were used to find the correlation between BMI with their prognostic abilities like cardiovascular disease and Diabetes Mellitus Type 2. We have considered statistically significant every p value less than 0.05. RESULT: Over all 160 patients, the men presented the highest number of cases compared to female 73.1% and 26.9% respectively. The mean age resulted 52.7 ± 15.6 years and age groups 50-59 years old and 60-69 years old with 29.4% and 34.3% respectively were the most frequent in this study. About the category of BMI index 8.8% patients resulted underweight, 45% were in normal weight, 28.2% were pre-obese and 6.6% were obese. We observed significant correlations between BMI and some of the demographic data such as: gender, age, place of residence, educational level, smoking and alcohol consumption for p <0.05. Changes in patient survival rates between BMI with DMT2 and cardiovascular disease are not statistically significant (long range p> 0.05). In terms of mortality, a strong significant correlation was observed with the age of 50-69 years and with the index of hemoglobin, urea and creatinine after dialysis with p value <0.05. CONCLUSION: In the paradoxical epidemiology, the overweight becomes chronic on hemodialysis patients and serves as a protective factor which is associated with better survival, but we weren`t found significant association between the BMI and some of the variables analyzed. This study presents a small number of chronic patients on hemodialysis center in Elbasan city. There is a need to better understand the reverse epidemiological causes in individuals on dialysis, which can help us improve the poor outcome in this population.
No takes yet. Share an insight, caveat, or question.
Elezi et al. (2022) conducted a cross-sectional in End-stage renal disease on chronic hemodialysis (n=160). Body mass index (BMI) vs. Different BMI categories was evaluated on Correlation between BMI and mortality/survival (Pearson Correlation -0.065, p=0.413). Body mass index showed no statistically significant correlation with mortality or survival (Pearson correlation -0.065, p=0.413) among chronic hemodialysis patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: